Telo Genomics Corp. (TSXV:TELO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0500
+0.0050 (11.11%)
At close: Mar 9, 2026
-56.52%
Market Cap 5.02M
Revenue (ttm) n/a
Net Income (ttm) -2.62M
Shares Out 100.43M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 70,400
Average Volume 99,845
Open 0.0450
Previous Close 0.0450
Day's Range 0.0450 - 0.0500
52-Week Range 0.0400 - 0.1300
Beta 0.18
RSI 52.00
Earnings Date Feb 25, 2026

About Telo Genomics

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company’s TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SM... [Read more]

Sector Healthcare
CEO Sabine Mai
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol TELO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.